Table 2.
Types and grades of immune-related adverse events described in our cohort.
| No. (%) | GRADE (%) 1 2 3 4 |
||||
|---|---|---|---|---|---|
| Infusion reaction | 1 (1.8) | 100.0 | – | – | – |
| Endocrine | 5 (9.1) | 40.0 | 60.0 | – | – |
| Pneumonitis | 6 (10.9) | 16.7 | 66.7 | 16.7 | |
| Colitis | 2 (3.6) | – | 100.0 | – | – |
| Hepatitis | 3 (5.5) | 33.3 | 33.3 | – | 33.3 |
| Nephritis | 4 (7.3) | 25.0 | 25.0 | 50.0 | – |
| Neurologic | 1 (1.8) | – | – | 100.0 | – |
| Musculoskeletal | 5 (9.1) | 40.0 | 20.0 | 40.0 | – |
| Skin | 6 (10.9) | 50.0 | 33.3 | 16.7 | – |
| Cardiovascular | 1 (1.8) | – | – | 100.0 | – |
| Ocular | 1 (1.8) | 100.0 | – | – | – |
| Other | 1 (1.8) | – | 100.0 | – | – |